This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Factors influencing care for patients with gynecologic malignancies from culturally and linguistically diverse backgrounds: a questionnaire study (iCALD-2).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial.
Nature communications · 2026
Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2025
Latest funding
- $1,923,621
Image-based quantitative assessment of tumor hypoxia
CIHR · 2014 · Principal investigator
- $245,857
Hypoxia in micrometastases as a cause of treatment failure in the adjuvant setting
CIHR · 2012 · Co-investigator
44 publications.
Factors influencing care for patients with gynecologic malignancies from culturally and linguistically diverse backgrounds: a questionnaire study (iCALD-2).
Kasherman L, Braik D, Gonzalez-Ochoa E, Shukla A, Odujoko O, Lajkosz K, Wang C, Grant R, Dhani N, Bowering V, Croke J, Philp L, Oza A, Lheureux S
Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial.
Veneziani AC, Lheureux S, Millar DG, Dhani N, Colombo I, Madariaga A, Soberanis Pina P, Atale S, Chan YL, Lee J, Ramsahai J, Quintos J, Wang L, Li X, Bowering V, Ohashi P, Wang B, Oza AM
Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer.
Collier E, Soberanis Pina P, McMullen M, Gonzalez-Ochoa E, Zou J, Zhao Z, Avery L, Bowering V, Msan A, Dhani N, Oza AM, Han K, Bratman SV, Lheureux S
Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors.
Alghabban A, Corke L, Katzberg H, Bril V, Barnett-Tapia C, Mason W, Alothman R, Albiruni Ryan AR, Hogg D, Sridhar S, Dhani N, Spreafico A, Eng L, Sacher A, Bradbury P, Liu G, Leighl N, Shepherd FA
Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada.
Snow S, Brezden-Masley C, Carter MD, Dhani N, Macaulay C, Ramjeesingh R, Raphael MJ, Slovinec D'Angelo M, Servidio-Italiano F
Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration.
Weaver AN, Iams WT, Park JC, Mita M, Holtick U, Gordon MS, Rodabaugh KJ, Dhani N, Neupane P, Taylor M, Amanda Duvall E, Jennings J, Miselis NR, Loughhead S, Warren MS, Bernstein H, Klussmann JP, Baranda J, Jimeno A
Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort Study.
Moffat GT, Coyne Z, Albaba H, Aung KL, Dodd A, Espin-Garcia O, Moura S, Gallinger S, Kim J, Fraser A, Hutchinson S, Moulton CA, Wei A, McGilvray I, Dhani N, Jang R, Elimova E, Moore M, Prince R, Knox J
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.
Jimeno A, Baranda J, Iams WT, Park JC, Mita M, Gordon MS, Taylor M, Dhani N, Leal AD, Neupane P, Eng C, Yeku O, Mita A, Moser JC, Butler M, Loughhead SM, Jennings J, Miselis NR, Ji RR, Nair N, Kornacker M, Zwirtes RF, Bernstein H, Sharei A
Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature.
Fournier C, Hirsch I, Spreafico A, Butler MO, Dhani N, Sauder MB
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.
Zimmermann C, Pope A, Hannon B, Bedard PL, Rodin G, Dhani N, Li M, Herx L, Krzyzanowska MK, Howell D, Knox JJ, Leighl NB, Sridhar S, Oza AM, Lheureux S, Booth CM, Liu G, Castro JA, Swami N, Sue-A-Quan R, Rydall A, Le LW
Image-based quantitative assessment of tumor hypoxia
Principal investigators: Jaffray, David A; Coolens, Catherine; Dhani, Neesha C; Hedley, David W; Joshua, Anthony; Lee, Ting-Yim; Milosevic, Michael; Palma, David; Valliant, John F; Wouters, Bradly; Yeung, Ivan Wai Tong
Keywords: Quantitative Assessment
Hypoxia in micrometastases as a cause of treatment failure in the adjuvant setting
Principal investigators: Hedley, David W
Keywords: Adjuvant Chemotherapy; Hypoxia; Metastasis; Pancreatic Cancer
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medical Oncology
- Medical Biophysics
- Epidemiology Division
- Psychosocial Oncology and Palliative Care
- Biostatistics Division
- Department of Surgery
- Oncology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Steven Gallinger
Medical Biophysics
9 shared papers, latest 2024
Stephanie Lheureux
Medical Oncology
9 shared papers, latest 2026
David Hedley
Medical Oncology
8 shared papers, latest 2022
Jennifer Croke
Faculty
5 shared papers, latest 2026
Lisa Wang
Biostatistics Division
4 shared papers, latest 2022
Breffni Hannon
Faculty
3 shared papers, latest 2023
Jenny Lau
Oncology
3 shared papers, latest 2023
John Kim
Neuropsychology
3 shared papers, latest 2024
Michael Milosevic
Radiation Medicine
3 shared papers, latest 2022
Eran Shlomovitz
Department of Surgery
3 shared papers, latest 2023
Srikala Sridhar
Faculty
3 shared papers, latest 2025
Geoffrey Liu
Epidemiology Division
3 shared papers, latest 2025
Dongsheng Tu
Faculty
2 shared papers, latest 2010
Robert Grant
Medical Biophysics
2 shared papers, latest 2026
Doris Howell
Psychosocial Oncology and Palliative Care
2 shared papers, latest 2023
Anna Spreafico
Faculty
2 shared papers, latest 2025
Faiyaz Notta
Medical Biophysics
2 shared papers, latest 2018
Marcus Butler
Immunology
2 shared papers, latest 2023
Kathy Han
Faculty
2 shared papers, latest 2025
Madeline Li
Psychiatry
2 shared papers, latest 2023
Gary Rodin
Epidemiology Division
2 shared papers, latest 2023
Pablo Serrano Aybar
Surgery
2 shared papers, latest 2019
Catherine O'Brien
Surgery and Cancer
2 shared papers, latest 2019
Ian Mcgilvray
Surgery
2 shared papers, latest 2024
Camilla Zimmermann
Psychosocial Oncology and Palliative Care
2 shared papers, latest 2023
Ming-Sound Tsao
Department of Laboratory Medicine and Pathobiology
2 shared papers, latest 2019
Elena Elimova
Faculty
1 shared papers, latest 2024
Amit Oza
Faculty
1 shared papers, latest 2026
Ting-Yim Lee
Biochemistry
1 shared papers, latest 2022
Marianne Koritzinsky
Faculty
1 shared papers, latest 2022
Elaine McWhirter
Oncology
1 shared papers, latest 2022
Steven Narod
Epidemiology Division
1 shared papers, latest 2015
David Jaffray
Pharmaceutical Sciences
1 shared papers, latest 2022
Daniel Durocher
Lunenfeld-Tanenbaum Research Institute
1 shared papers, latest 2017
Alice Wei
General Surgery
1 shared papers, latest 2014
Jinzi Zheng
Faculty
1 shared papers, latest 2009
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.